AXL signaling in cancer: from molecular insights to targeted therapies

Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance